Japanese encephalitis (JE) is a serious health concern in China, with approximately 80% of global infections occurring in China. To develop effective prevention and control strategies, this study explored the epidemiological characteristics of JE in China based on spatiotemporal data, to understand the...
Japanese encephalitis virus (JEV) was first detected in New South Wales in February 2022. As few infections lead to clinical disease, estimating the number of infections in humans is difficult. The new: One in eleven serosurvey participants, drawn from five regional NSW towns deemed to be at risk on...
Japanese encephalitis virus (JEV) annually infects a substantial population in the Asia‐Pacific region, particularly in rural and suburban areas (Baluni et al., 2018; Mulvey et al., 2021). Its primary impact is on children, leading to severe conditions such as meningoencephalomyelitis,...
Japanese encephalitis is caused by the Japanese encephalitis virus (JEV). JEV is the main cause of viral encephalitis in Asia, and is endemic in many countries on that continent and islands of the Pacific region. Although only a small percentage of cases are symptomatic, 20–30% are fatal and 30–50%...
Japanese encephalitis (JE) is the main cause of acute encephalitis syndrome (AES) in South Asia, including India. There are 68 000 cases globally per year. Vector control is not so effective and difficult to implement. However, JE vaccination is reported to be an effective approach in various...